|
Volumn 127, Issue 6, 2011, Pages 1410-1411
|
Pathogen-specific IgG antibody levels in immunodeficient patients receiving immunoglobulin replacement do not provide additional benefit to therapeutic management over total serum IgG
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BACTERIUM ANTIBODY;
IMMUNOGLOBULIN;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN G ANTIBODY;
PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIBODY;
PNEUMOCOCCUS POLYSACCHARIDE;
TETANUS ANTIBODY;
TETANUS TOXOID;
UNCLASSIFIED DRUG;
ANTIBODY BLOOD LEVEL;
BLOOD SAMPLING;
BRONCHIECTASIS;
CHEST INFECTION;
DIAGNOSTIC KIT;
ENZYME LINKED IMMUNOSORBENT ASSAY;
GEOMETRY;
GROUP A STREPTOCOCCAL INFECTION;
HAEMOPHILUS INFECTION;
HAEMOPHILUS INFLUENZAE TYPE B;
HAEMOPHILUS PARAINFLUENZAE;
HUMAN;
HUMORAL IMMUNE DEFICIENCY;
IMMUNOASSAY;
IMMUNOGLOBULIN BLOOD LEVEL;
IMMUNOTHERAPY;
LETTER;
MAJOR CLINICAL STUDY;
PRIMARY ANTIBODY DEFICIENCY;
PRIORITY JOURNAL;
SECONDARY ANTIBODY DEFICIENCY;
STREPTOCOCCUS PNEUMONIAE;
STREPTOCOCCUS PYOGENES;
TURBIDIMETRY;
|
EID: 79957828895
PISSN: 00916749
EISSN: 10976825
Source Type: Journal
DOI: 10.1016/j.jaci.2011.01.035 Document Type: Article |
Times cited : (32)
|
References (5)
|